J30
Conditions
Interventions
Group 1: Probiotic (Enterococcus faecalis) for 4 weeks, 3 x 30 droplets per day
Group 2: Placebo for 4 weeks, 3 x 30 droplets per day
Group 3: open-label placebo for 4 weeks, 3 x 30 droplets per day
G
Sponsors
Medical School Berlin
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Allergic rhinitis for at least two years. Allergic rhinitis must have been diagnosed by a physician.
Exclusion criteria
Exclusion criteria: Inability to read and understand the study information; insufficient German language skills; a medical history of diabetes; gastrointestinal diseases; use of antibiotic medication in the last 6 weeks; pregnancy; perennial allergic rhinitis; chronic rhinosinusitis or any other chronic nasal condition such as anatomical alterations as septum deviation or perforation; any known psychiatric or neurological diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Allergic symptoms and haelth related quality of life before and after the treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual-analogue scale to measure the burden of allergic disease and second questionnaire on quality of life before and after the treatment. | — |
Countries
Germany
Contacts
Public ContactMichael Schaefer
Medical School Berlin
Outcome results
None listed